LENSAR, Inc.

NasdaqCM:LNSR 주식 리포트

시가총액: US$68.9m

LENSAR 향후 성장

Future 기준 점검 2/6

LENSAR 의 수익은 연간 68.2% 감소할 것으로 예상되는 반면, 연간 수익은 21.1% 로 증가할 것으로 예상됩니다. EPS는 연간 86.1% 만큼 쇠퇴할 것으로 예상됩니다.

핵심 정보

-68.2%

이익 성장률

-86.08%

EPS 성장률

Medical Equipment 이익 성장16.2%
매출 성장률21.1%
향후 자기자본이익률n/a
애널리스트 커버리지

Low

마지막 업데이트08 May 2026

최근 향후 성장 업데이트

Recent updates

내러티브 업데이트 Jun 03

LNSR: Post Deal Selloff Will Set Up Margin Led Repricing Potential

Analysts have lifted their price target on LENSAR to $10, citing stronger profit margin expectations, a lower assumed discount rate, and a reduced future P/E, even as projected revenue growth is now more conservative. Analyst Commentary Bullish Takeaways Bullish analysts highlight the $10 price target as reflecting confidence that LENSAR's expected profit margins can support a higher valuation multiple than previously assumed.
내러티브 업데이트 May 04

LNSR: Buy Thesis Will Rebuild Around Post Deal Selloff And Adoption Reacceleration

Analysts have nudged their price target on LENSAR stock to $8.50, with recent upgrades to Buy and renewed confidence around the ALLY System adoption story cited as key reasons for the updated view. Analyst Commentary Recent research has focused on how the ALLY System adoption story and the fallout from the halted Alcon acquisition are shaping expectations for LENSAR’s execution and valuation.
내러티브 업데이트 Apr 19

LNSR: Buy Thesis Rebuilds Around Post Deal Selloff And Adoption Reacceleration

Analysts have raised their price targets on LENSAR shares to $10, citing renewed optimism around ALLY System adoption and viewing the post acquisition setback selloff as a second chance for investors. Analyst Commentary Bullish Takeaways Bullish analysts point to a $10 price target as a simple yardstick for how they frame upside potential if ALLY System adoption trends seen before the Alcon deal announcement can be re established.
새로운 내러티브 Apr 17

Cataract Procedure Bundling Will Pressure Margins Yet Recurring Revenue Should Support Gradual Recovery

Catalysts About LENSAR LENSAR develops and commercializes robotic femtosecond laser systems for cataract surgery, with a focus on its ALLY Robotic Laser Cataract System. What are the underlying business or industry changes driving this perspective?
내러티브 업데이트 Apr 03

LNSR: Buy Rating Resets Around Post Deal Selloff And Execution Rebuild

Analysts have trimmed their price target for LENSAR to $8.50 from $12.50, reflecting updated views on revenue growth, profitability and a lower future P/E, while also pointing to recent upgrades that highlight renewed interest in the stock following the failed Alcon acquisition. Analyst Commentary Recent Street research has focused on the reset expectations for LENSAR following the failed Alcon transaction, as well as the potential runway for the company’s ALLY System.
새로운 내러티브 Mar 31

Recurring Cataract Procedure Revenue And Machine Learning Will Transform This Undervalued Medical Device Story

Catalysts About LENSAR LENSAR develops and commercializes the ALLY Robotic Laser Cataract System for laser assisted cataract surgery. What are the underlying business or industry changes driving this perspective?
내러티브 업데이트 Mar 19

LNSR: Buy Rating And Post Deal Reset Will Drive Future Reassessment

Analysts have trimmed their fair value estimate for LENSAR from $15.00 to $12.50, pointing to revised assumptions around discount rates, margins, and future P/E, alongside a BTIG upgrade to Buy that highlights past ALLY System adoption and the recent post acquisition selloff as a potential second chance for investors to reassess the story. Analyst Commentary Bullish Takeaways Bullish analysts highlight that the cut in fair value to $12.50 still sits above the current $10 price target.
User avatar
새로운 내러티브 May 10

Global System Placements Will Improve Operating Room Efficiency

Strong system placements and contract pipelines in international markets enhance potential for sustained revenue growth and competitive advantage.
분석 기사 Jan 28

Even With A 28% Surge, Cautious Investors Are Not Rewarding LENSAR, Inc.'s (NASDAQ:LNSR) Performance Completely

Despite an already strong run, LENSAR, Inc. ( NASDAQ:LNSR ) shares have been powering on, with a gain of 28% in the...
분석 기사 Dec 24

We're Hopeful That LENSAR (NASDAQ:LNSR) Will Use Its Cash Wisely

There's no doubt that money can be made by owning shares of unprofitable businesses. By way of example, LENSAR...
분석 기사 Oct 24

Market Might Still Lack Some Conviction On LENSAR, Inc. (NASDAQ:LNSR) Even After 28% Share Price Boost

LENSAR, Inc. ( NASDAQ:LNSR ) shareholders would be excited to see that the share price has had a great month, posting a...
분석 기사 Sep 12

LENSAR (NASDAQ:LNSR) Is In A Good Position To Deliver On Growth Plans

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
분석 기사 Jul 16

LENSAR, Inc. (NASDAQ:LNSR) Doing What It Can To Lift Shares

With a price-to-sales (or "P/S") ratio of 1.3x LENSAR, Inc. ( NASDAQ:LNSR ) may be sending bullish signals at the...
분석 기사 May 01

Here's Why Shareholders May Want To Be Cautious With Increasing LENSAR, Inc.'s (NASDAQ:LNSR) CEO Pay Packet

Key Insights LENSAR to hold its Annual General Meeting on 7th of May Salary of US$541.1k is part of CEO Nick Curtis's...
분석 기사 Feb 22

LENSAR, Inc.'s (NASDAQ:LNSR) Shares Leap 33% Yet They're Still Not Telling The Full Story

LENSAR, Inc. ( NASDAQ:LNSR ) shares have continued their recent momentum with a 33% gain in the last month alone...
분석 기사 Jan 24

Here's Why We're Watching LENSAR's (NASDAQ:LNSR) Cash Burn Situation

We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...
분석 기사 Dec 20

Not Many Are Piling Into LENSAR, Inc. (NASDAQ:LNSR) Just Yet

LENSAR, Inc.'s ( NASDAQ:LNSR ) price-to-sales (or "P/S") ratio of 0.7x might make it look like a strong buy right now...
분석 기사 Oct 21

Here's Why We're A Bit Worried About LENSAR's (NASDAQ:LNSR) Cash Burn Situation

We can readily understand why investors are attracted to unprofitable companies. For example, although...
분석 기사 Sep 13

Investors Continue Waiting On Sidelines For LENSAR, Inc. (NASDAQ:LNSR)

LENSAR, Inc.'s ( NASDAQ:LNSR ) price-to-sales (or "P/S") ratio of 0.9x might make it look like a strong buy right now...
분석 기사 Mar 21

This Broker Just Slashed Their LENSAR, Inc. (NASDAQ:LNSR) Earnings Forecasts

One thing we could say about the covering analyst on LENSAR, Inc. ( NASDAQ:LNSR ) - they aren't optimistic, having just...
분석 기사 Mar 18

Will LENSAR (NASDAQ:LNSR) Spend Its Cash Wisely?

Just because a business does not make any money, does not mean that the stock will go down. For example, although...
분석 기사 Nov 01

Here's Why We're Not Too Worried About LENSAR's (NASDAQ:LNSR) Cash Burn Situation

We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...
Seeking Alpha Aug 08

LENSAR GAAP EPS of -$0.67, revenue of $8M

LENSAR press release (NASDAQ:LNSR): Q2 GAAP EPS of -$0.67. Revenue of $8M (+1.3% Y/Y).  Adjusted EBITDA was -$4.3M for the quarter ended June 30, 2022 and -$2.3M for the quarter ended June 30, 2021.  As of June 30, 2022, the company had cash and cash equivalents of $25.2M as compared to $31.6M at December 31, 2021. Based on its cash position and operational forecasts, the company believes it has sufficient cash to fund operations into 2024.
분석 기사 Mar 23

LENSAR (NASDAQ:LNSR) Is In A Good Position To Deliver On Growth Plans

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
분석 기사 Jul 28

We Think LENSAR (NASDAQ:LNSR) Can Afford To Drive Business Growth

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...

이익 및 매출 성장 예측

NasdaqCM:LNSR - 애널리스트 향후 추정치 및 과거 재무 데이터 (USD Millions)
날짜매출이익자유현금흐름영업현금흐름평균 애널리스트 수
12/31/20281069N/AN/A1
12/31/202773-4N/AN/A2
12/31/20266130N/AN/A2
3/31/20265829-12-12N/A
12/31/202558-34-15-15N/A
9/30/202559-52-12-12N/A
6/30/202558-49-5-5N/A
3/31/202557-57-4-4N/A
12/31/202453-31-2-2N/A
9/30/202449-17-7-6N/A
6/30/202445-14-10-10N/A
3/31/202445-12-9-8N/A
12/31/202342-14-10-10N/A
9/30/202340-13-14-14N/A
6/30/202338-18-19-18N/A
3/31/202334-18-19-19N/A
12/31/202235-20-15-15N/A
9/30/202236-21-11-11N/A
6/30/202237-23-9-8N/A
3/31/202237-21-7-7N/A
12/31/202134-20-9-9N/A
9/30/202132-23-11-10N/A
6/30/202130-21-8-8N/A
3/31/202128-21-12-12N/A
12/31/202026-20-14-14N/A
9/30/202027-15-19-19N/A
6/30/202027-16-22-21N/A
3/31/202029-15-19-17N/A
12/31/201931-15N/A-13N/A
12/31/201824-14N/A-2N/A

애널리스트 향후 성장 전망

수입 대 저축률: LNSR 의 수익은 향후 3년간 감소할 것으로 예상됩니다(연간 -68.2%).

수익 vs 시장: LNSR 의 수익은 향후 3년간 감소할 것으로 예상됩니다(연간 -68.2%).

고성장 수익: LNSR 의 수익은 향후 3년간 감소할 것으로 예상됩니다.

수익 대 시장: LNSR 의 수익(연간 21.1%)이 US 시장(연간 12.5%)보다 빠르게 성장할 것으로 예상됩니다.

고성장 매출: LNSR 의 수익(연간 21.1%)은 연간 20%보다 빠르게 증가할 것으로 예상됩니다.


주당순이익 성장 예측


향후 자기자본이익률

미래 ROE: LNSR의 자본 수익률이 3년 후 높을 것으로 예상되는지 판단하기에 데이터가 부족합니다.


성장 기업 찾아보기

기업 분석 및 재무 데이터 상태

데이터최종 업데이트 (UTC 시간)
기업 분석2026/06/10 12:04
종가2026/06/10 00:00
수익2026/03/31
연간 수익2025/12/31

데이터 소스

당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.

패키지데이터기간미국 소스 예시 *
기업 재무제표10년
  • 손익계산서
  • 현금흐름표
  • 대차대조표
분석가 컨센서스 추정치+3년
  • 재무 예측
  • 분석가 목표주가
시장 가격30년
  • 주가
  • 배당, 분할 및 기타 조치
지분 구조10년
  • 주요 주주
  • 내부자 거래
경영진10년
  • 리더십 팀
  • 이사회
주요 개발10년
  • 회사 공시

* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.

별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.

분석 모델 및 스노우플레이크

이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드YouTube 튜토리얼도 제공합니다.

Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.

산업 및 섹터 지표

산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.

분석가 소스

LENSAR, Inc.는 3명의 분석가가 다루고 있습니다. 이 중 2명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.

분석가기관
Michael GormanBTIG
Frank TakkinenLake Street Capital Markets, LLC
Richard NewitterLeerink Partners LLC